AtriCure, Inc.’s Post

View organization page for AtriCure, Inc., graphic

36,951 followers

Dr. Saumil R. Oza highlights contemporary trials like CEASE-AF and CONVERGE, discussing their impact on Afib treatment and the role of Hybrid ablation. Tune in to hear more. See the data behind these studies: https://okt.to/QoyDES #hybridAFtherapy #Epeeps #CardiacSurgery

Ovidio A. García-Villarreal

President of the Examination Board for Judiciary Experts at the Mexican College of Cardiovascular & Thoracic Surgery.

3mo

Beyond a shadow of a doubt, hybrid ablation is infinitely superior to the sole endocardial ablation in non-paroxysmal AF. That’s out of discussion. However, the turning point to consider is how effective as freedom from AF with no anti arrhythmic drugs is the procedure at longer follow-ups than just 1.5, 2 or 3 years. Maybe 5 yr may shed some light about this therapy focused on non-paroxysmal AF. Let’s wait for the very long results.

To view or add a comment, sign in

Explore topics